CPC
MRNA icon

Cookson Peirce & Co’s Moderna MRNA Stock Holding History

Cookson Peirce & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,956
Closed -$890K – 243
2022
Q4 		$890K Buy
+4,956
New +$810K 0.06% 108
2021
Q4 		– Sell
-4,982
Closed -$1.92M – 229
2021
Q3 		$1.92M Sell
4,982
-4,229
-46% -$1.56M 0.12% 97
2021
Q2 		$2.16M Buy
+9,211
New +$1.65M 0.13% 94

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cookson Peirce & Co's MRNA Position: Q1 2023 in Review

Cookson Peirce & Co sold out of Moderna (MRNA) in Q1 2023, closing a stake of 4,956 shares — an estimated $890K sold.

Cookson Peirce & Co first reported a position in MRNA in Q2 2021 and held it in 3 quarters. The position peaked at $2.16M in Q2 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Cookson Peirce & Co reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Cookson Peirce & Co sold 4,956 Moderna shares in Q1 2023, an estimated $890K.
  • Cookson Peirce & Co first reported a position in Moderna in Q2 2021 and held it in 3 quarters.
  • Cookson Peirce & Co's Moderna position peaked at $2.16M in Q2 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Cookson Peirce & Co's 13F filing for Q1 2023, filed 3 May 2023.